• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

BDH Industries Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4720.0
  • ISIN : INE278D01018
510.75 -5 (-0.90%)
  • As on 14 Sep 2026 (EOD)

  • Today’s Low

    505.55

  • Today’s High

    515.00

  • Open

    508.15

  • Perv Close

    515.40

  • 52W Low

    306.00

  • 52W High

    610.00

Key Indicators

  • P/E(TTM)

    25.12

  • Mar.Cap (₹Cr.)

    294.19

  • Div & Yield %

    0.98

  • Book Value(₹)

    131.42

  • Debt-Equity Ratio

    -0.90

  • AGM Date

    11-Sep-2026

  • EPS

    20.33

  • P/E Ratio

    25.12

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    294.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.76

  • BV (₹)

    131.40

  • Sales( ₹ in Cr.)

    95.95

  • NP (in Cr.)

    10.81

  • NP Var(%)

    17.0

  • Div%

    50.0

  • CPS (₹)

    20.30

  • EPS (₹)

    18.80

  • Traded Value (₹ in Lakhs)

    294.19

  • 52 Week High

    610.00

  • 52 Week Low

    306.00

  • Price BSE

    511.0

  • Price NSE

    1.00

  • Market Capital( in Cr.)

    294.19

  • P/C Ratio

    25.20

  • P/E Ratio

    27.20

  • Price Vs.BV

    18.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 95.95 66.51 85.83 74.46 69.39 57.45
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 95.95 66.51 85.83 74.46 69.39 57.45
Other Income 2.24 1.84 1.58 0.84 1.33 1.30
Stock Adjustments 0.61 1.00 -0.61 -1.89 0.55 1.17
Total Income 98.80 69.35 86.80 73.41 71.27 59.92
EXPENDITURE :            
Raw Materials 70.53 42.39 59.66 47.80 49.53 38.35
Power and Fuel Cost 1.35 1.76 1.78 1.74 1.41 1.49
Employee Cost 7.55 7.44 7.43 6.96 6.62 6.26
Other Manufacturing Expenses 0.53 0.63 0.62 0.86 0.43 0.97
Selling and Administration Expenses 2.48 3.45 3.10 4.09 2.67 2.84
Miscellaneous Expenses 0.25 0.22 0.19 0.18 0.21 0.20
Employee Benefit Expenses 7.55 7.44 7.43 6.96 6.62 6.26
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 82.69 55.89 72.79 61.62 60.87 50.11
Operating Profit 16.12 13.44 14.01 11.80 10.42 9.81
Interest 0.06 0.07 0.18 0.16 0.23 0.28
Gross Profit 16.06 13.37 13.83 11.64 10.19 9.53
Depreciation 0.87 0.91 0.57 0.57 0.63 0.79
Profit Before Tax 15.19 12.46 13.26 11.07 9.56 8.74
Current Tax 3.54 2.54 2.94 2.87 2.33 2.45
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.84 0.65 0.44 -0.01 0.00 -0.06
Reported Net Profit 10.81 9.27 9.87 8.20 7.22 6.36
Extraordinary Items 0.00 0.00 0.00 0.00 0.34 0.00
Adjusted Net Profit 10.81 9.27 9.87 8.20 6.88 6.36
Adjustment below Net Profit 0.03 -0.08 -0.10 -0.01 0.04 -0.08
P & L Balance brought forward 45.76 40.55 34.54 29.65 25.20 21.31
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.21 3.98 3.76 3.30 2.81 2.39
P & L Balance carried down 52.39 45.76 40.55 34.54 29.65 25.20
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 45.00 45.00 40.00 36.00 30.00
Dividend Per Share(Rs) 5.00 4.50 4.50 4.00 3.60 3.00
Earnings Per Share-Unit Curr 18.78 16.11 17.14 14.25 12.55 10.71
Earnings Per Share(Adj)-Unit Curr 18.78 16.11 17.14 14.25 12.55 10.71
Book Value 131.47 117.14 105.67 92.71 82.07 70.24
Book Value(Adj)-Unit Curr 131.47 117.14 105.67 92.71 82.07 70.24

Shareholding Pattern

  • Promoter Group

    49.70%

  • Public Share Holding

    50.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 464,380 464,380.00 464,380 464,380
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 464,380 8.07 464,380 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,396,760 41.63 2,396,760 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,396,760 41.63 2,396,760 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,024 0.28 16,024 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,024 0.28 16,024 1
2] Non Institution
Bodies Corporate 8,167 0.14 8,067 20
Clearing Members 211,387 3.67 211,387 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 75,467 1.31 75,467 75
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 319,966 5.56 319,966 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 234,300 4.07 234,300 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,442,979 25.06 1,368,779 4,366
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 587,870 10.21 587,870 96
Sub Total 2,880,136 50.03 2,805,836 4,568
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,757,300 100.00 5,683,000 4,587

Company Background

BDH Industries LtdPharmaceuticals - Indian - Formulations

  • BDH Industries Ltd
  • BSE Code : 4720.0
  • ISIN : INE278D01018

  • Incorporation Year

    1990

  • Registered Office

    Nair Baug
    Akurli Road Kandivli (E), Mumbai,
    Maharashtra-400101

  • Telephone

    91-22-28871370/28870834

  • FAX

    91-22-28868349

  • Chairman

    Jayashree Nair

  • Managing Director

    Jayashree Nair

  • Company Secretary

    Nikita Phatak

  • Auditor

    CLB & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

BDH Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
BDH Industries 510.75 98.20 95.95 25.12 20.82
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77